Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3218400
Max Phase: Preclinical
Molecular Formula: C37H59N13O16
Molecular Weight: 941.95
Molecule Type: Small molecule
Associated Items:
ID: ALA3218400
Max Phase: Preclinical
Molecular Formula: C37H59N13O16
Molecular Weight: 941.95
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](OC(=O)NCCCCCn2cc(CCCCNC(=O)O[C@@H]([C@@H]3OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]3NC(C)=O)[C@H](O)CO)nn2)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N
Standard InChI: InChI=1S/C37H59N13O16/c1-17(53)44-26-20(46-34(38)39)12-24(32(57)58)63-30(26)28(22(55)15-51)65-36(61)42-9-5-3-7-11-50-14-19(48-49-50)8-4-6-10-43-37(62)66-29(23(56)16-52)31-27(45-18(2)54)21(47-35(40)41)13-25(64-31)33(59)60/h12-14,20-23,26-31,51-52,55-56H,3-11,15-16H2,1-2H3,(H,42,61)(H,43,62)(H,44,53)(H,45,54)(H,57,58)(H,59,60)(H4,38,39,46)(H4,40,41,47)/t20-,21-,22+,23+,26+,27+,28+,29+,30+,31+/m0/s1
Standard InChI Key: BSWAILVCOXMZEZ-LDYAYRTQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 941.95 | Molecular Weight (Monoisotopic): 941.4203 | AlogP: -4.89 | #Rotatable Bonds: 25 |
Polar Surface Area: 463.35 | Molecular Species: ZWITTERION | HBA: 19 | HBD: 16 |
#RO5 Violations: 3 | HBA (Lipinski): 29 | HBD (Lipinski): 18 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.08 | CX Basic pKa: 11.82 | CX LogP: -9.21 | CX LogD: -9.21 |
Aromatic Rings: 1 | Heavy Atoms: 66 | QED Weighted: 0.02 | Np Likeness Score: 0.01 |
1. Fraser BH, Hamilton S, Krause-Heuer AM, Wright PJ, Greguric I, Tucker SP, Draffan AG, Fokin VV, Sharpless KB. (2013) Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza A and B, 4 (2): [10.1039/C2MD20300F] |
Source(1):